Extended Medtronic EMEA co-marketing cooperation

Schwarzer Cardiotek GmbH (SCT) and Medtronic Inc. (MDT) have reached an agreement to extend the existing co-marketing agreement on the SCT Electrophysiology-technology portfolio (that previously was in place exclusively for the German market) to cover all EMEA as from Oct 1st, 2017. The co-marketing agreement means that Medtronic Inc. have the option to promote the Schwarzer Cardiotek EP-TRACER product family to their customers as part of a commercial agreement. Frank-P. Klein (CEO of SCT) commented: “The extended co-marketing agreement with Medtronic is a proof of SCT’s quality and capacity as a medical solutions provider. Medtronic is one of the leaders in the Healthcare industry today and we are very proud of being recognized as a valuable partner to them. We expect to see our marketshare grow in 2018 and beyond as a result of this cooperation”

Toshiba Medical Systems - European distribution agreement


Schwarzer Cardiotek introduces software version 2.2 for the electrophysiological measuring system EP-TRACER.


Schwarzer Cardiotek receives FDA 510(k) clearance for software version 2


EP-TRACER - The Film


New User Reports about EP-TRACER Portable


Schwarzer Cardiotek presents software version 2 of its electrophysiogical measuring system EP-TRACER


Schwarzer Cardiotek concludes filling of key management-level positions


Philips und Schwarzer Cardiotek conclude reseller agreement for the cardiology information system cardWorks


Schwarzer GmbH, Heilbronn Germany, And Cardiotek B.V., Maastricht, The Netherlands Announces That The Two Companies Will Merge Under The New Brand Of Schwarzer Cardiotek


Cardiotek Announces U.S. Commercialization of the EP-Tracer System Company to Showcase the System at 2014 HRS Meeting